Adial Pharmaceuticals, Inc - Common Stock — Bilancio Trimestrale (NASDAQ:ADIL) | MetaTrader

Apri il grafico completo Full chart

Notizie

Adial Pharmaceuticals deposita domanda di brevetto per AD04

Adial Pharmaceuticals richiede l’accesso al programma FDA priority voucher

Adial Pharmaceuticals completa la produzione del lotto dimostrativo di AD04

Adial Pharmaceuticals Lead Drug Fits New Policy Mood As Bipartisan Bill Signals Broader Lens On Alcohol Use Disorder - Adial Pharmaceuticals (NASDAQ:ADIL)

Adial Pharmaceuticals firma accordo quadro con Molteni per l’Europa

Adial Pharmaceuticals signs framework deal with Molteni for Europe

EXCLUSIVE: Adial Pharma Eyes Europe Deal For Lead Drug For Alcohol Use Disrder Worth Up To $60 Million - Adial Pharmaceuticals (NASDAQ:ADIL)

Adial Pharmaceuticals in rialzo dopo il cambio di politica della FDA

Adial Pharmaceuticals stock rises on FDA policy shift

Adial Pharmaceuticals punta a un unico studio pivotale per AD04

Adial Pharmaceuticals eyes single pivotal trial path for AD04

Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories! - TipRanks.com